As drug misuse increases and new drugs continually enter the market, Randox Toxicology has responded by developing innovative solutions for fast and accurate forensic drug screening. Biochip Array Technology has become a prevalent screening method providing advancement on traditional ELISA principles. A range of multiplex testing platforms are available to suit a variety of settings from the emergency room to the mortuary.
Drugs of Abuse Array I Plus
Amphetamine
Barbiturates
Benzodiazepine 1
Benzodiazepine 2
Cannabinoids
Cocaine metabolite (Benzoylecgonine)
MDMA
Methadone
Methamphetamine
Opiates
Phencyclidine
Tricyclic Antidepressants (TCAs Generic)
Creatinine*
Drugs of Abuse Array II
Buprenorphine
Fentanyl
Generic Opioids
Ketamine
LSD
MDMA
Methaqualone
Oxycodone 1
Oxycodone 2
Propoxyphene
Creatinine*
Drugs of Abuse Array III
Chloral Hydrate Metabolite
Ethyl Glucuronide
Fentanyl
Ketamine Metabolite
Meperidine
Meprobamate
Zaleplon
Zolpidem
Zopiclone
7-amino Flunitrazepam
Creatinine*
Drugs of Abuse Array IV
Acetaminophen
Dextromethorphan
Escitalopram
Fluoxetine
Haloperidol
Ibuprofen
Methylphenidate
Salicylate
Salicyluric acid
Sertraline
Tramadol
Trazodone
Tricyclic Antidepressants (TCAs Generic)
Creatinine*
Drugs of Abuse Array V
Benzylpiperazines
MDPV
Mephedrone
Mescaline
Phenylpiperazines
Salvinorin
Synthetic Cannabinoids
Creatinine*
*Creatinine is included as a marker of dilution for urine
Key Benefits of the Drugs of Abuse Arrays
• Simultaneous screening – consolidation offers a one-shot drug screen profile
• Reduced turnaround time – up to 13 times faster than ELISA
• Reduced costs – improve laboratory efficiency • Multiple forensic matrices – one flexible system for all testing requirements
• Diagnostic quality results – improves laboratory efficiency
• Optimisation in a range of forensic matrices – reduces false results
• Small sample volume – allowing more for confirmatory analysis
• Reduced sample preparation – further time and labour saving
• Reduction in false results – increasing laboratory workflow
• Excellent specificity – ensuring accurate results
• Excellent correlation with confirmatory methods – minimising un-necessary tests
• Built in adulteration check – provides confidence in results
• Best Practice principles – meeting accreditation requirements
• Dual applications for batch or STAT analysis – flexibility to suit your requirements
• Applications for onsite rapid testing – to meet the growing demand for near-patient screening